doi: 10.1007/s11655-024-3763-z 230 YaoTYaoYYWangJZJiangSMLiLJ
I could see a scenario where someone is very sensitive to the gastrointestinal side effects of GLP-1s, where microdosing might be considered, said Dr
Why Long-Term Risks Are Still Uncertain GLP-1 drugs are relatively new, and large-scale studies have primarily focused on: 612 month use diabetes-specific outcomes cardiovascular risk reduction What we dont have yet: long-term (515 year) safety data long-term pancreatic outcome studies long-term GI motility tracking full population data on chronic or permanent side effects long-term cancer risk data Large numbers of patients now take GLP-1 drugs indefinitely , especially for weight loss
Regular physical activity supports GLP-1 production, improves insulin sensitivity, and produces weight loss benefits that compound over time
Clear whey is still whey, so it is not dairy-free
It is still a full agonist for all 3 receptors but it is selective for AMY1 so it is more likely to bind to this receptor while having more muted effects on the other two
